Skip to main content

Reach IPS partners with VistaLifeSciences to use i360 in South Africa

By: PRLog
Reach IPS Partners with VistaLifeSciences to Provide Comprehensive Solutions for Remote Patient Monitoring
CUPERTINO, Calif. - Aug. 8, 2018 - PRLog -- California based Reach IPS and Parker CO based VistaLifeSciences, Inc. announced that they have signed a letter of intent/MOU to integrate their technologies to provide a comprehensive treatment solution for remote patient monitoring in South Africa.

VistaLifeSciences's proprietary clinical pathways and EHR software improves real time event management at the point-of-care. They provide intelligent analytics and support to doctors, and healthcare professionals (Nurse Practitioners, Physician Assistants, and other clinicians) to enhance the lives of patients with various disease states including HIV.

Reach IPS i360 is a mobile healthcare iOT system that allows health and wellness providers to deliver effective clinical care plans through a modern consumer wearable devices. Inside its delivery system, i360 features a platform that collects and analyzes a wide range of block chain data available through various medical devices.  Team this technology up with the ability to connect and monitor multiple patient centric devices which deliver a complete patient performance assessment as well as multiple care plan protocols specific to the user.

"VistaLifeSciences is excited to partner with Reach IPS for their i360 technologies. With the proper device data integration with our patient centric-spectrum differential algorithms, we will provide quicker and more accurate diagnoses for a specific disease syndrome, thus reducing health care costs for hospitals, enabling doctors and remote clinical care to provide personalized medicine, and to improve the quality of life for their patients." –Peg Molloy, Chief Strategy Officer and Co-founder of VistaLifeSciences, Inc.

David A Wanner, MBA/MHA., Chief Administrative Officer of Reach IPS added, "We at Reach IPS are very excited about collaborating with VistaLifeSciences.  We are all about creating digital health opportunities to enhance patient lives worldwide and create increased provider efficacy.  This is a primary value statement for both entities. VistaLifeSciences is pioneering remote mobile symptom tracking, and diagnostic categorization application and Reach IPS cutting-edge i360 advanced patient monitoring push forward increased diagnostic accuracy from remote and wearable devices.

Both companies are leaders in their respective verticals and together create significant potential for the industry and patient."

About VistaLifeSciences

VistaLifeSciences offers clinical decision support, patient assessment and EHR software for use at point-of-care and in telemedicine.  Healthcare professionals, from physicians to community health workers, use our software to improve patient lives by expediting the time to proper diagnosis, care and management. Our Apps standardize data collection, provide guided easy-to-use data capture, and include patented, peer-reviewed and globally used patient assessment tools.  We improve workflow, consistency, patient experience and, most importantly, reduce misdiagnosis. Learn more at www.VistaLifeSciences.com

About Reach IPS

Reach IPS is a digital health innovator, building the bridge between wearable devices and patient care.  i360 provides hundreds of predefined treatment plans, with the ability to customize, combine and manage any number of devices, caregivers and patient groups, while using your EMR/EHR software of choice. 360 supports almost every biomedical and fitness/wearable device while integrating into most leading EMR systems. i360 promotes healthier lifestyles without making lifestyle changes.

Visit www.ReachIPS.com to learn more.

Contact
David Wanner
dwanner@reachips.com

Media Contact
David A. Wanner
***@reachips.com
877-282-1609

Photos: (Click photo to enlarge)

Reach IPS Logo

Read Full Story - Reach IPS partners with VistaLifeSciences to use i360 in South Africa | More news from this source

Press release distribution by PRLog

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.